CBX7 expression was significantly lower in advanced tumor stages (pT3 vs. pT2, p = 0.0013, Figure 6B) and in tumors with high (> 7) compared to low (< 7) Gleason Scores (p = 0.0167, Figure 6C). Here, CBX7 is linked to neoplasm.